164 related articles for article (PubMed ID: 22214909)
1. Gd-EOB-DTPA-enhanced MR imaging findings of hepatocellular adenoma: correlation with pathological findings.
Takara K; Saito K; Kusama H; Tsuchida A; Aoki T; Nagao T; Imai Y; Taira J; Moriyasu F; Tokuuye K
Magn Reson Med Sci; 2011; 10(4):245-9. PubMed ID: 22214909
[TBL] [Abstract][Full Text] [Related]
2. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
[TBL] [Abstract][Full Text] [Related]
3. Enhancement pattern of hepatocellular adenoma (HCA) on MR imaging performed with Gd-EOB-DTPA versus other Gd-based contrast agents (GBCAs): An intraindividual comparison.
Cannella R; Brancatelli G; Rangaswamy B; Minervini MI; Borhani AA; Furlan A
Eur J Radiol; 2019 Oct; 119():108633. PubMed ID: 31437747
[TBL] [Abstract][Full Text] [Related]
4. OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy.
Sciarra A; Schmidt S; Pellegrinelli A; Maggioni M; Dondossola D; Pasquier J; Cigala C; Tosi D; Halkic N; Bulfamante G; Viale G; Bosari S; Balabaud C; Bioulac-Sage P; Sempoux C
Liver Int; 2019 Jan; 39(1):158-167. PubMed ID: 30218633
[TBL] [Abstract][Full Text] [Related]
5. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
[TBL] [Abstract][Full Text] [Related]
6. Gd-EOB-DTPA-Enhanced Magnetic Resonance Findings of a Giant Inflammatory Hepatocellular Adenoma: a Case Report and Review of the Literature.
Di Pietropaolo M; Briani C; Pilozzi E; Carbonetti F; David V; Iannicelli E
J Gastrointest Cancer; 2015 Dec; 46(4):421-5. PubMed ID: 25894634
[No Abstract] [Full Text] [Related]
7. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
8. Dynamic MR imaging of hepatic adenomas with pathologic correlation.
Miyazaki T; Yamashita Y; Yamamoto H; Yoshimatsu S; Takahashi M; Ogawa M; Ishimaru Y
Comput Med Imaging Graph; 1994; 18(5):373-80. PubMed ID: 7954314
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
Auer TA; Fehrenbach U; Grieser C; Penzkofer T; Geisel D; Schmelzle M; Müller T; Bläker H; Seehofer D; Denecke T
Eur Radiol; 2020 Jun; 30(6):3497-3506. PubMed ID: 32086574
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte-specific magnetic resonance imaging contrast agents.
Fidler J; Hough D
Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
[No Abstract] [Full Text] [Related]
11. Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol.
Schelhorn J; Best J; Reinboldt MP; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S
J Vasc Interv Radiol; 2015 Jul; 26(7):972-9. PubMed ID: 25937296
[TBL] [Abstract][Full Text] [Related]
12. Enhancements in hepatobiliary imaging: the spectrum of gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid usages in hepatobiliary magnetic resonance imaging.
Channual S; Pahwa A; Lu DS; Raman SS
Abdom Radiol (NY); 2016 Sep; 41(9):1825-41. PubMed ID: 27225503
[TBL] [Abstract][Full Text] [Related]
13. Contrast agent Gd-EOB-DTPA (EOB·Primovist®) for low-field magnetic resonance imaging of canine focal liver lesions.
Yonetomi D; Kadosawa T; Miyoshi K; Nakao Y; Homma E; Hanazono K; Yamada E; Nakamura K; Ijiri A; Minegishi N; Maetani S; Hirayama K; Taniyama H; Nakade T
Vet Radiol Ultrasound; 2012; 53(4):371-80. PubMed ID: 22548505
[TBL] [Abstract][Full Text] [Related]
14. The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.
Wang YC; Chou CT; Lin CP; Chen YL; Chen YF; Chen RC
PLoS One; 2017; 12(3):e0174594. PubMed ID: 28355258
[TBL] [Abstract][Full Text] [Related]
15. A case of Budd-Chiari syndrome: Gd-EOB-DTPA-enhanced MR findings.
Kitajima K; Yoshikawa T; Seo Y; Ohno Y; Yano Y; Miki A; Kanda T; Kanata N; Azuma T; Sugimura K
Magn Reson Imaging; 2011 May; 29(4):579-83. PubMed ID: 21216550
[TBL] [Abstract][Full Text] [Related]
16. Multiple hepatocellular adenomas in a patient with glycogen storage disease type I: various enhancement patterns in MRI with Gd-EOB-DTPA.
Sakamoto A; Hayashi H; Sakamoto I; Isomoto I; Eguchi S; Takatsuki M; Kanematsu T; Abe K; Hayashi T; Uetani M
Abdom Imaging; 2012 Apr; 37(2):239-43. PubMed ID: 21416130
[TBL] [Abstract][Full Text] [Related]
17. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
18. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.
Zech CJ; Herrmann KA; Reiser MF; Schoenberg SO
Magn Reson Med Sci; 2007; 6(1):43-52. PubMed ID: 17510541
[TBL] [Abstract][Full Text] [Related]
19. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B.
Lee JH; Kim YR; Lee GM; Ryu JH; Cho EY; Lee YH; Yoon KH
Eur J Radiol; 2018 May; 102():95-101. PubMed ID: 29685552
[TBL] [Abstract][Full Text] [Related]
20. Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase.
Saito K; Kotake F; Ito N; Ozuki T; Mikami R; Abe K; Shimazaki Y
Magn Reson Med Sci; 2005; 4(1):1-9. PubMed ID: 16127248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]